1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
Babu, C.R.
Flynn, P.F.
Wand, A.J.
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
1
90.00
90.00
90.00
1.000
1.000
1.000
C3 H7 N O2
89.093
y
ALANINE
L-peptide linking
C6 H15 N4 O2 1
175.209
y
ARGININE
L-peptide linking
C4 H8 N2 O3
132.118
y
ASPARAGINE
L-peptide linking
C4 H7 N O4
133.103
y
ASPARTIC ACID
L-peptide linking
C5 H10 N2 O3
146.144
y
GLUTAMINE
L-peptide linking
C5 H9 N O4
147.129
y
GLUTAMIC ACID
L-peptide linking
C2 H5 N O2
75.067
y
GLYCINE
peptide linking
C6 H10 N3 O2 1
156.162
y
HISTIDINE
L-peptide linking
C6 H13 N O2
131.173
y
ISOLEUCINE
L-peptide linking
C6 H13 N O2
131.173
y
LEUCINE
L-peptide linking
C6 H15 N2 O2 1
147.195
y
LYSINE
L-peptide linking
C5 H11 N O2 S
149.211
y
METHIONINE
L-peptide linking
C9 H11 N O2
165.189
y
PHENYLALANINE
L-peptide linking
C5 H9 N O2
115.130
y
PROLINE
L-peptide linking
C3 H7 N O3
105.093
y
SERINE
L-peptide linking
C4 H9 N O3
119.119
y
THREONINE
L-peptide linking
C9 H11 N O3
181.189
y
TYROSINE
L-peptide linking
C5 H11 N O2
117.146
y
VALINE
L-peptide linking
US
J.Am.Chem.Soc.
JACSAT
0004
0002-7863
123
2691
2692
10.1021/ja005766d
11456950
Validation of protein structure from preparations of encapsulated proteins dissolved in low viscosity fluids.
2001
US
Proc.Natl.Acad.Sci.USA
PNASA6
0040
0027-8424
95
15299
15302
10.1073/pnas.95.26.15299
High-resolution NMR of encapsulated proteins dissolved in low-viscosity fluids
1998
NE
J.Biomol.NMR
JBNME9
0800
0925-2738
14
75
78
10.1023/A:1008354507250
Preparation of encapsulated proteins dissolved in low viscosity fluids
1999
10.2210/pdb1g6j/pdb
pdb_00001g6j
1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
8576.831
UBIQUITIN
1
man
polymer
no
no
MQIFVKTLTGKTITLEVEPSDTIENVKAKIQDKEGIPPDQQRLIFAGKQLEDGRTLSDYNIQKESTLHLVLRLRGG
MQIFVKTLTGKTITLEVEPSDTIENVKAKIQDKEGIPPDQQRLIFAGKQLEDGRTLSDYNIQKESTLHLVLRLRGG
A
polypeptide(L)
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
human
Homo
Escherichia
Escherichia coli
sample
9606
Homo sapiens
469008
Escherichia coli BL21(DE3)
BL21(DE3)
PET
PET15
database_2
pdbx_nmr_software
pdbx_struct_assembly
pdbx_struct_oper_list
repository
Initial release
Version format compliance
Version format compliance
Data collection
Database references
Derived calculations
1
0
2001-03-28
1
1
2008-04-27
1
2
2011-07-13
1
3
2022-02-23
_database_2.pdbx_DOI
_database_2.pdbx_database_accession
_pdbx_nmr_software.name
crystal structure of ubiquitin
structure of ubiquitin in aqueous buffer
RCSB
Y
RCSB
2000-11-06
REL
REL
lowest target function values
100
32
3D_13C-separated_NOESY
3D_15N-separated_NOESY
HNHA
ambient
293
K
50
psi
293
K
The structures are based on 1805 NOEs and 63 phi restraints
torsion angle dynamics using DYANA
25
closest to the average
4 mg c13/n15 ubiquitin in 13.5 ul of buffer (50mM Sodium acetate, 250mM Sodium Chloride, pH 5.0) and 1 ml D12-pentane
75mM bis(2-ethyl hexyl) sulfosuccinate in d-pentane
8 mg 13/n15 ubiquitin in 27 ul of buffer (50mM Sodium acetate, 250mM Sodium Chloride, pH 5.0)
75mM bis(2-ethyl hexyl) sulfosuccinate in butane
4 mg n15 ubiquitin in 13.5 ul of buffer (50mM Sodium acetate, 250mM Sodium Chloride, pH 5.0)
75mM bis(2-ethyl hexyl) sulfosuccinate in d-pentane
Guntert, P., Mumenthaler, C., Wuthrich, K.
refinement
DYANA
1.5
MSI, San Diego, CA
processing
Felix
97
Bartels, C.X., Guntert, P., Billeter, M., Wuthrich, K.
data analysis
XEASY
1.2
750
Varian
INOVA
600
Varian
INOVA
MET
1
n
1
MET
1
A
GLN
2
n
2
GLN
2
A
ILE
3
n
3
ILE
3
A
PHE
4
n
4
PHE
4
A
VAL
5
n
5
VAL
5
A
LYS
6
n
6
LYS
6
A
THR
7
n
7
THR
7
A
LEU
8
n
8
LEU
8
A
THR
9
n
9
THR
9
A
GLY
10
n
10
GLY
10
A
LYS
11
n
11
LYS
11
A
THR
12
n
12
THR
12
A
ILE
13
n
13
ILE
13
A
THR
14
n
14
THR
14
A
LEU
15
n
15
LEU
15
A
GLU
16
n
16
GLU
16
A
VAL
17
n
17
VAL
17
A
GLU
18
n
18
GLU
18
A
PRO
19
n
19
PRO
19
A
SER
20
n
20
SER
20
A
ASP
21
n
21
ASP
21
A
THR
22
n
22
THR
22
A
ILE
23
n
23
ILE
23
A
GLU
24
n
24
GLU
24
A
ASN
25
n
25
ASN
25
A
VAL
26
n
26
VAL
26
A
LYS
27
n
27
LYS
27
A
ALA
28
n
28
ALA
28
A
LYS
29
n
29
LYS
29
A
ILE
30
n
30
ILE
30
A
GLN
31
n
31
GLN
31
A
ASP
32
n
32
ASP
32
A
LYS
33
n
33
LYS
33
A
GLU
34
n
34
GLU
34
A
GLY
35
n
35
GLY
35
A
ILE
36
n
36
ILE
36
A
PRO
37
n
37
PRO
37
A
PRO
38
n
38
PRO
38
A
ASP
39
n
39
ASP
39
A
GLN
40
n
40
GLN
40
A
GLN
41
n
41
GLN
41
A
ARG
42
n
42
ARG
42
A
LEU
43
n
43
LEU
43
A
ILE
44
n
44
ILE
44
A
PHE
45
n
45
PHE
45
A
ALA
46
n
46
ALA
46
A
GLY
47
n
47
GLY
47
A
LYS
48
n
48
LYS
48
A
GLN
49
n
49
GLN
49
A
LEU
50
n
50
LEU
50
A
GLU
51
n
51
GLU
51
A
ASP
52
n
52
ASP
52
A
GLY
53
n
53
GLY
53
A
ARG
54
n
54
ARG
54
A
THR
55
n
55
THR
55
A
LEU
56
n
56
LEU
56
A
SER
57
n
57
SER
57
A
ASP
58
n
58
ASP
58
A
TYR
59
n
59
TYR
59
A
ASN
60
n
60
ASN
60
A
ILE
61
n
61
ILE
61
A
GLN
62
n
62
GLN
62
A
LYS
63
n
63
LYS
63
A
GLU
64
n
64
GLU
64
A
SER
65
n
65
SER
65
A
THR
66
n
66
THR
66
A
LEU
67
n
67
LEU
67
A
HIS
68
n
68
HIS
68
A
LEU
69
n
69
LEU
69
A
VAL
70
n
70
VAL
70
A
LEU
71
n
71
LEU
71
A
ARG
72
n
72
ARG
72
A
LEU
73
n
73
LEU
73
A
ARG
74
n
74
ARG
74
A
GLY
75
n
75
GLY
75
A
GLY
76
n
76
GLY
76
A
author_defined_assembly
1
monomeric
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
x,y,z
identity operation
0.0000000000
0.0000000000
0.0000000000
A
N
LEU
15
A
N
LEU
15
A
O
ILE
3
A
O
ILE
3
A
N
PHE
4
A
N
PHE
4
A
O
SER
65
A
O
SER
65
A
N
VAL
70
A
N
VAL
70
A
O
ARG
42
A
O
ARG
42
A
N
PHE
45
A
N
PHE
45
A
O
LYS
48
A
O
LYS
48
2
A
A
H
OD2
GLU
ASP
18
21
1.54
2
A
A
O
H
ILE
GLU
30
34
1.58
6
A
A
H
OD2
GLU
ASP
18
21
1.53
7
A
A
H
OD2
GLU
ASP
18
21
1.55
8
A
A
H
OD2
GLU
ASP
18
21
1.55
8
A
A
O
H
GLU
ARG
51
54
1.56
8
A
A
O
HG
GLN
SER
62
65
1.57
8
A
A
O
H
ILE
GLU
30
34
1.58
9
A
A
H
OD2
GLU
ASP
18
21
1.53
10
A
A
H
OD2
GLU
ASP
18
21
1.57
11
A
A
H
OD2
GLU
ASP
18
21
1.54
11
A
A
OE1
HG
GLN
SER
62
65
1.55
12
A
A
H
OD2
GLU
ASP
18
21
1.55
13
A
A
H
OH
GLU
TYR
51
59
1.55
15
A
A
H
OD2
GLU
ASP
18
21
1.52
16
A
A
H
OD2
GLU
ASP
18
21
1.54
16
A
A
O
HG
GLN
SER
62
65
1.56
16
A
A
H
O
MET
VAL
1
17
1.59
19
A
A
H
OD2
GLU
ASP
18
21
1.54
20
A
A
H
OD2
GLU
ASP
18
21
1.55
22
A
A
H
OD2
GLU
ASP
18
21
1.55
23
A
A
O
HG
GLN
SER
62
65
1.60
24
A
A
H
OD2
GLU
ASP
18
21
1.55
25
A
A
HE22
O
GLN
ARG
40
74
1.57
26
A
A
H
OD2
GLU
ASP
18
21
1.53
27
A
A
H
OD2
GLU
ASP
18
21
1.54
27
A
A
O
H
PHE
LYS
45
48
1.59
28
A
A
H
OD2
GLU
ASP
18
21
1.52
29
A
A
H
OD2
GLU
ASP
18
21
1.53
30
A
A
H
OD2
GLU
ASP
18
21
1.53
31
A
A
H
OD2
GLU
ASP
18
21
1.55
32
A
A
O
H
GLU
ARG
51
54
1.51
1
A
LYS
33
-77.13
-73.21
1
A
LEU
73
-80.05
-72.95
1
A
ARG
74
-86.20
-149.56
2
A
LYS
33
-79.10
-70.03
2
A
ASP
52
-47.41
104.76
2
A
ARG
74
-90.16
-153.50
3
A
LYS
33
-74.72
-73.05
3
A
ASP
52
-47.01
104.00
3
A
ARG
74
-90.19
-149.98
4
A
LYS
33
-74.84
-73.02
4
A
ASP
52
-47.17
104.22
4
A
ARG
74
-90.15
-150.69
5
A
THR
9
-99.73
44.41
5
A
LYS
33
-75.41
-74.81
5
A
ASP
52
-46.96
102.65
5
A
ARG
74
-90.11
-150.02
6
A
LYS
33
-79.73
-71.13
6
A
ASP
52
-47.05
105.63
6
A
ARG
74
-90.39
-156.27
7
A
LYS
33
-74.41
-75.12
7
A
ARG
74
-90.10
-149.94
8
A
ARG
74
-90.25
-150.18
9
A
LYS
33
-77.29
-74.94
9
A
LEU
73
-78.55
-73.56
10
A
THR
9
-99.71
39.87
10
A
LYS
33
-74.74
-77.50
10
A
ASP
52
-46.77
104.00
10
A
LEU
73
-79.45
-71.96
10
A
ARG
74
-90.34
-150.32
11
A
ASP
52
-47.42
104.81
11
A
ASN
60
60.85
66.20
11
A
LEU
73
-79.58
-70.84
11
A
ARG
74
-90.09
-150.03
12
A
THR
9
-99.48
43.82
12
A
LYS
33
-74.73
-72.46
12
A
ASP
52
-47.35
104.01
12
A
LEU
73
-77.30
-71.28
12
A
ARG
74
-90.35
-153.70
13
A
LYS
33
-74.64
-74.87
13
A
ARG
74
-90.07
-150.21
14
A
LYS
33
-74.58
-71.53
14
A
ASP
52
-47.41
106.35
14
A
ARG
74
-87.44
-149.93
15
A
LYS
33
-75.07
-78.23
15
A
ASP
52
-47.39
104.62
15
A
ASN
60
62.57
66.19
15
A
ARG
74
-90.31
-151.25
16
A
LYS
33
-78.76
-77.45
16
A
ARG
74
-90.23
-150.83
17
A
LYS
33
-75.11
-75.44
17
A
ALA
46
55.02
19.87
17
A
ASP
52
-47.16
103.39
17
A
LEU
73
-76.11
-73.44
17
A
ARG
74
-90.20
-150.07
18
A
LYS
33
-78.51
-72.94
18
A
ASP
52
-47.03
103.09
18
A
ARG
74
-90.08
-149.96
19
A
LYS
33
-80.39
-74.68
19
A
ASP
52
-47.13
104.99
19
A
ARG
74
-90.14
-150.17
20
A
LYS
33
-74.80
-78.01
20
A
ALA
46
58.60
17.92
20
A
ASP
52
-47.27
103.51
20
A
ARG
74
-90.19
-151.56
21
A
LYS
33
-80.84
-76.80
21
A
ASP
52
-48.12
108.37
21
A
ARG
74
-90.25
-150.13
22
A
LYS
33
-77.22
-77.00
22
A
ALA
46
59.17
16.82
22
A
ASP
52
-47.19
104.50
23
A
LYS
33
-76.12
-72.45
24
A
LYS
33
-76.16
-75.81
24
A
ASP
52
-47.13
105.62
25
A
LYS
33
-74.85
-78.49
25
A
ASP
52
-47.06
105.68
25
A
ASN
60
61.92
61.39
25
A
LEU
73
-79.91
-77.30
25
A
ARG
74
-81.04
-93.73
26
A
LYS
33
-75.01
-74.98
26
A
ASP
52
-47.10
102.93
26
A
LEU
73
-77.01
-70.92
26
A
ARG
74
-90.24
-150.24
27
A
LYS
33
-79.70
-75.08
27
A
ASP
52
-48.10
105.77
27
A
LEU
73
-80.19
-73.25
27
A
ARG
74
-90.21
-150.07
28
A
LYS
33
-75.59
-74.86
28
A
ASP
52
-46.93
104.77
28
A
ASN
60
65.02
64.71
28
A
ARG
74
-90.43
-158.46
29
A
LYS
33
-74.42
-77.05
29
A
ASP
52
-47.17
106.83
29
A
ASN
60
62.24
64.85
29
A
ARG
74
-90.24
-150.04
30
A
LYS
33
-81.96
-72.96
30
A
ASP
52
-46.83
104.23
30
A
LEU
73
-74.15
-70.50
30
A
ARG
74
-90.20
-150.02
31
A
LYS
33
-75.93
-76.51
31
A
ASP
52
-47.22
105.67
31
A
LEU
73
-79.94
-73.62
32
A
LYS
33
-80.55
-74.99
32
A
ARG
74
-90.11
-151.56
STRUCTURE OF RECOMBINANT HUMAN UBIQUITIN IN AOT REVERSE MICELLES
1
N
N
A
THR
22
A
THR
22
HELX_P
A
GLU
34
A
GLU
34
1
1
13
A
LEU
56
A
LEU
56
HELX_P
A
ASN
60
A
ASN
60
5
2
5
gene regulation, cell cycle
reverse micelle, AOT, encapsulation, gene regulation, cell cycle
UBIQ_HUMAN
UNP
1
1
P62988
MQIFVKTLTGKTITLEVEPSDTIENVKAKIQDKEGIPPDQQRLIFAGKQLEDGRTLSDYNIQKESTLHLVLRLRGG
1
76
1G6J
1
76
P62988
A
1
1
76
5
anti-parallel
parallel
anti-parallel
anti-parallel
A
THR
12
A
THR
12
A
GLU
16
A
GLU
16
A
GLN
2
A
GLN
2
A
LYS
6
A
LYS
6
A
SER
65
A
SER
65
A
VAL
70
A
VAL
70
A
ARG
42
A
ARG
42
A
PHE
45
A
PHE
45
A
LYS
48
A
LYS
48
A
GLN
49
A
GLN
49
1
P 1